Management of Prednison Therapy

Introduction to Prednison Tapering

• The American College of Rheumatology suggests that an abrupt cessation of prednison can lead to acute adrenal insufficiency, which may manifest as gastrointestinal symptoms such as diarrhea 1
• The European Association for the Study of the Liver recommends adjusting the prednison dose according to the current therapy course, considering the patient's previous dose and treatment duration 2

Guidelines for Prednison Reintroduction

• The patient should be advised to immediately reintroduce prednison with 3 tablets of 5 mg (15 mg) daily, followed by the originally planned tapering scheme, to minimize the risk of adrenal insufficiency 1
• The tapering scheme should be continued as follows: 3 tablets of 5 mg (15 mg) daily for 1 week, 2 tablets of 5 mg (10 mg) daily for 1 week, 1 tablet of 5 mg (5 mg) daily for 1 week, and 1/2 tablet of 5 mg (2.5 mg) daily for 1 week 2

Importance of Adherence to Therapy

• The patient should be informed that self-discontinuation of prednison can lead to severe complications, and the medication should not be stopped without medical consultation 1, 2
• Regular monitoring of symptoms, particularly diarrhea, is crucial, and medical evaluation should be sought if symptoms persist or worsen within 2-3 days 3, 2

Risks of Inadequate Prednison Management

• Too rapid tapering of prednison and abrupt cessation without medical consultation can increase the risk of adrenal insufficiency, which may manifest as diarrhea, nausea, or weakness 1, 2
• Ignoring symptoms of adrenal insufficiency can lead to severe complications, emphasizing the need for proper management and monitoring of prednison therapy 3, 2